GEMINI SPACE STATION INC-A (GEMI) Fundamental Analysis & Valuation

NASDAQ:GEMI • US36866J1051

Current stock price

4.4 USD
+0.03 (+0.69%)
Last:

This GEMI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. GEMI Profitability Analysis

1.1 Basic Checks

  • GEMI had negative earnings in the past year.
  • In the past year GEMI has reported a negative cash flow from operations.
GEMI Yearly Net Income VS EBIT VS OCF VS FCFGEMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 2025 -100M -200M -300M -400M -500M

1.2 Ratios

  • The Return On Assets of GEMI (-32.35%) is worse than 91.21% of its industry peers.
  • The Return On Equity of GEMI (-107.75%) is worse than 89.12% of its industry peers.
Industry RankSector Rank
ROA -32.35%
ROE -107.75%
ROIC N/A
ROA(3y)-22.9%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GEMI Yearly ROA, ROE, ROICGEMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 2025 0 100 -100 200

1.3 Margins

  • GEMI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GEMI Yearly Profit, Operating, Gross MarginsGEMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 2025 -100 -200 -300

3

2. GEMI Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for GEMI remains at a similar level compared to 1 year ago.
  • Compared to 1 year ago, GEMI has an improved debt to assets ratio.
GEMI Yearly Shares OutstandingGEMI Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2025 20M 40M 60M 80M 100M
GEMI Yearly Total Debt VS Total AssetsGEMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • GEMI has an Altman-Z score of -1.59. This is a bad value and indicates that GEMI is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -1.59, GEMI is doing worse than 88.28% of the companies in the same industry.
  • GEMI has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
  • GEMI has a better Debt to Equity ratio (0.42) than 68.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Altman-Z -1.59
ROIC/WACCN/A
WACCN/A
GEMI Yearly LT Debt VS Equity VS FCFGEMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 2025 0 200M -200M 400M

2.3 Liquidity

  • A Current Ratio of 1.29 indicates that GEMI should not have too much problems paying its short term obligations.
  • GEMI has a Current ratio (1.29) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.29 indicates that GEMI should not have too much problems paying its short term obligations.
  • GEMI's Quick ratio of 1.29 is in line compared to the rest of the industry. GEMI outperforms 59.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.29
GEMI Yearly Current Assets VS Current LiabilitesGEMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 2025 500M 1B 1.5B

4

3. GEMI Growth Analysis

3.1 Past

  • GEMI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -662.01%.
  • GEMI shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.31%.
EPS 1Y (TTM)-662.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-426.78%
Revenue 1Y (TTM)26.31%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%39.36%

3.2 Future

  • Based on estimates for the next years, GEMI will show a very strong growth in Earnings Per Share. The EPS will grow by 21.36% on average per year.
  • GEMI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 33.39% yearly.
EPS Next Y42%
EPS Next 2Y28.21%
EPS Next 3Y21.36%
EPS Next 5YN/A
Revenue Next Year40.37%
Revenue Next 2Y39.97%
Revenue Next 3Y33.39%
Revenue Next 5YN/A

3.3 Evolution

GEMI Yearly Revenue VS EstimatesGEMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
GEMI Yearly EPS VS EstimatesGEMI Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 -1 -2 -3 -4 -5

1

4. GEMI Valuation Analysis

4.1 Price/Earnings Ratio

  • GEMI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year GEMI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GEMI Price Earnings VS Forward Price EarningsGEMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GEMI Per share dataGEMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10

4.3 Compensation for Growth

  • GEMI's earnings are expected to grow with 21.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.21%
EPS Next 3Y21.36%

0

5. GEMI Dividend Analysis

5.1 Amount

  • GEMI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

GEMI Fundamentals: All Metrics, Ratios and Statistics

GEMINI SPACE STATION INC-A

NASDAQ:GEMI (4/28/2026, 1:28:12 PM)

4.4

+0.03 (+0.69%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-19
Earnings (Next)N/A
Inst Owners26.75%
Inst Owner Change0.02%
Ins Owners1.86%
Ins Owner Change1.23%
Market Cap527.96M
Revenue(TTM)179.57M
Net Income(TTM)-582.81M
Analysts70
Price Target10.63 (141.59%)
Short Float %18.49%
Short Ratio3.98
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-171.34%
Min EPS beat(2)-329.99%
Max EPS beat(2)-12.7%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)11.51%
Min Revenue beat(2)6.19%
Max Revenue beat(2)16.84%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-30.96%
PT rev (3m)-53.87%
EPS NQ rev (1m)-4.54%
EPS NQ rev (3m)-56.14%
EPS NY rev (1m)-8.42%
EPS NY rev (3m)-10.03%
Revenue NQ rev (1m)-4.44%
Revenue NQ rev (3m)-23%
Revenue NY rev (1m)-20.45%
Revenue NY rev (3m)-24.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.94
P/FCF N/A
P/OCF N/A
P/B 0.98
P/tB 1.32
EV/EBITDA N/A
EPS(TTM)-10.29
EYN/A
EPS(NY)-3.11
Fwd EYN/A
FCF(TTM)-1.88
FCFYN/A
OCF(TTM)-1.82
OCFYN/A
SpS1.5
BVpS4.51
TBVpS3.34
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -32.35%
ROE -107.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-22.9%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 24.94%
Cap/Sales 4.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 1.29
Altman-Z -1.59
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)21.54%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.18%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-662.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-426.78%
EPS Next Y42%
EPS Next 2Y28.21%
EPS Next 3Y21.36%
EPS Next 5YN/A
Revenue 1Y (TTM)26.31%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%39.36%
Revenue Next Year40.37%
Revenue Next 2Y39.97%
Revenue Next 3Y33.39%
Revenue Next 5YN/A
EBIT growth 1Y-122.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year19.03%
EBIT Next 3Y17.36%
EBIT Next 5YN/A
FCF growth 1Y-96.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-100.17%
OCF growth 3YN/A
OCF growth 5YN/A

GEMINI SPACE STATION INC-A / GEMI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GEMINI SPACE STATION INC-A (GEMI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to GEMI.


What is the valuation status for GEMI stock?

ChartMill assigns a valuation rating of 1 / 10 to GEMINI SPACE STATION INC-A (GEMI). This can be considered as Overvalued.


What is the profitability of GEMI stock?

GEMINI SPACE STATION INC-A (GEMI) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for GEMI stock?

The Earnings per Share (EPS) of GEMINI SPACE STATION INC-A (GEMI) is expected to grow by 42% in the next year.